Satellite Symposium - Assessing Fracture Risk: the Future for Designing New Therapies

5 May 2010, Florence, Italy.
The Osteoporotic Virtual Physiological Human (VPHOP) Consortium organizes a symposium entitled "Assessing fracture risk: the future for designing new therapies" which will be held during the IOF WCO-ECCEO10 Congress in Florence, Italy. The symposium will take place in Hall B, Spadolini Pavillion - Fortezza da Basso, Viale Filippo Strozzi 1. The event will provide an opportunity to present the clinical community the early results of the VPHOP project on the new technology to fight osteoprosis.

The symposium program aims to present to the clinical experts the state of the art in technologies to assess the risk of fractures in patients affected by osteoporosis.

Moderators of the symposium will be the VPHOP Project Coordinator, Marco Viceconti and the chair of the VPHOP Clinical Committee, Renè Rizzoli.

The program of the event is the following:

  • 14:00-14:15 Renè Rizzoli (Geneva University Hospital): The role of technology in the fight against osteoporosis
  • 14:15-14:30 Dieter Felsenberg (Charité, Berlin): Clinical prospectives on osteoporosis: bone and muscle
  • 14:30-14:45 Fulvia Taddei (Istituto Ortopedico Rizzoli, Bologna): New technologies to predict the risk of fracture
  • 15:00-15:15 Bert van Rietbergen (Technical University Eindhoven): Tissue level imaging for critical risk assessment
  • 14:45-15:00 Ralph Müller (ETH Zurich): Cell and tissue based simulation of osteoporosis and pharmacological treatment
  • 15:15-15:30 Marco Viceconti (Istituto Ortopedico Rizzoli, Bologna): Personalised, predictive, and integrative medicine: future scenarios for osteoporosis

To attend the satellite symposium you have to be registered to the International Osteoporosis Foundation (IOF) World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis - http://www.iofwco-ecceo10.org
Florence, May 5-8, 2010

For further information, please visit: http://www.vphop.eu

About the Osteoporotic Virtual Physiological Human (VPHOP)
VPHOP is a Collaborative Integrated Project that is developing simulation-based technology to predict the risk of bone fracture in osteoporosis patients. Co-funded by the European Commission as part of the Seventh Framework Program. The project runs for four years starting from September 2008. Coordinated by Rizzoli Orthopaedic Institute, the Project Consortium gathers 19 European Organisations based in Italy, The Netherlands, Germany, Switzerland, Belgium, France, United Kingdom, Sweden, and Iceland.

For more information: http://www.vphop.eu.

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...